RXDProShares UltraShort Health Care
RXD Fund Description
RXD provides -2x exposure to a market-cap-weighted index of US financial services companies.
RXD Factset Analytics Insight
RXD provides daily geared inverse (-2x) exposure to the Dow Jones US Health Care Index. It charges 95 bps for holding swaps on the index and the iShares US Healthcare ETF (IYH). The index has about a 65% stake in the pharmaceuticals alone, making RXD, in essence, a leveraged bet against the pharmaceutical industry. RXD has next to nothing in AUM and carries a high fund-closure risk. It has nonexisting liquidity, with low daily trading volume and wide spreads, making RXD a very poor and expensive trading vehicle. Considering RXD is a tactical tool, the onerous costs of trading undermine the product’s usefulness. Due to daily compounding, it’s unlikely to achieve its stated exposure and returns for longer than a 1-day period.
RXD CHARTS AND PERFORMANCE
RXD Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of RXD. RXD is rated a N/A out of 5.